Unclaimed brand
✅ ТОВ "ОмніФарма" – українська фармацевтична компанія з виробництва лікарських засобів і дієтичних добавок ✅ Телефони ☎ 044-377-51-14; 044-377-51-15; 044-377-51-16
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#EB2F31
Alizarin Crimson
235, 47, 49
359, 82, 55
0, 80, 79, 8
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#2F4B00
Verdun Green
47, 75, 0
82, 100, 15
37, 0, 100, 71
ОмніФарма is a Ukrainian pharmaceutical company that specializes in the production of medicinal products and dietary supplements. With a commitment to the latest approaches in medicine, they develop and introduce health products with proven effectiveness. All of their products meet strict medical safety standards, ensuring the well-being and health of individuals.
The development and production process of their own medications adheres to three key principles: scientifically and clinically proven efficacy of active ingredients, rigorous control of raw material quality, and international manufacturing standards. Their extensive range of products includes Agapta, Alba, Bile Vugillia, YoSen, and Capsument, each with unique benefits for various health concerns. With over 50 dedicated team members, OmniPharma has been serving the market since 2008 and exporting to 14 foreign countries.
Their commitment to high-quality products and health standards makes them a trusted brand in the pharmaceutical industry. Contact them at +38 044-377-51-14 to learn more or visit their website
Company type
Privately Held
Year founded
2008
Company size
51-200 employees
How do I download the OmniFarma LLC logo?
The OmniFarma LLC logo comes as a dark logo. Download as SVG or transparent PNG.
What are OmniFarma LLC's brand colors?
The OmniFarma LLC color palette uses the hex codes #EB2F31, #FFFFFF and #2F4B00.
The OmniFarma LLC name, logos and brand assets are trademarks of OmniFarma LLC and its affiliates. Brandfetch isn't affiliated with or endorsed by OmniFarma LLC. Their use is subject to OmniFarma LLC's brand guidelines.
